Oncology · Phase II

Top sponsors

• First People's Hospital 261 programs
• Chinese Academy of 198 programs
• George Institute for 118 programs
• United Therapeutics Europe 112 programs
• Telethon Foundation 91 programs
• Takeda 79 programs
• Regeneron UK 71 programs
• MSD Merck Sharp 63 programs
• Ningbo Cancer Hospital 62 programs
• Anaxis Pharma 57 programs
• AstraZeneca 52 programs
• HOFFMANN-LA ROCHE 50 programs

1. GEN1047 DP

   Genmab A/S

   Malignant Solid Tumors

   phase 2 · small molecule · active

   1 trial →

2. GEN1078 DP

   Genmab A/S

   Malignant solid tumors

   phase 2 · small molecule · active

   1 trial →

3. GIM35-RIBOSIL

   Fondazione Telethon ETS

   hormone receptor positive, HER2-negative breast cancer

   phase 2 · small molecule · active

   1 trial →

4. GIMEMA ALL2922

   Fondazione Telethon ETS

   Adult Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia.

   phase 2 · small molecule · active

   1 trial →

5. GINECO- CE111b

   Ningbo Cancer Hospital

   Patients with a histilogically confirmed diagnosis of cervical squamous or adenosquamous carcinoma stage IB3 if N>=1 or II to IVA with any N stage according to FIGO 2018 and no evidence of metastatic disease (M0), without any prior anti-cancer treatment.

   phase 2 · other · active

   1 trial →

6. GINECO-EN203b

   Ningbo Cancer Hospital

   metastatic or recurrent endometrial or ovarian carcinosarcoma

   phase 2 · small molecule · active

   1 trial →

7. GINECO-OV243b

   Ningbo Cancer Hospital

   Patients with a confirmed diagnosis of ovarian small cell carcinoma.

   phase 2 · small molecule · active

   1 trial →

8. GINECO-OV244b

   Ningbo Cancer Hospital

   Platinum sensitive recurrent ovarian cancer

   phase 2 · small molecule · active

   1 trial →

9. GLPG5101

   Lakefront Biotherapeutics NV

   Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

   phase 2 · gene therapy · active

   1 trial →

10. GM-CT-01

    GALECTIN THERAPEUTICS INC

    Colorectal Cancer

    phase 2 · small molecule · terminated

    2 trials →

11. GM-CT-01

    GALECTIN THERAPEUTICS INC

    Cancer of the Bile Duct

    phase 2 · small molecule · terminated

    1 trial →

12. GM-CT-01 plus 5-Fluorouracil

    GALECTIN THERAPEUTICS INC

    Colorectal Cancer

    phase 2 · small molecule · terminated

    1 trial →

13. GO40516

    Hoffmann-La Roche

    B-cell non-Hodgkin lymphoma (NHL)

    phase 2 · small molecule · active

    1 trial →

14. GO40554

    Hoffmann-La Roche

    Diffuse Large B-Cell Lymphoma (DLBCL)

    phase 2 · small molecule · active

    1 trial →

15. GO42216

    Hoffmann-La Roche

    Advanced liver cancers

    phase 2 · small molecule · active

    1 trial →

16. GO43075

    Hoffmann-La Roche

    Diffuse Large B-Cell Lymphoma

    phase 2 · small molecule · active

    1 trial →

17. GO44096

    Hoffmann-La Roche

    Solid Tumors

    phase 2 · other · active

    1 trial →

18. GO45434

    Hoffmann-La Roche

    Relapsed/Refractory Aggressive B-Cell Non-Hodgkin’s Lymphoma (NHL)

    phase 2 · other · active

    1 trial →

19. GRAALL2014

    Pari Pharma GmbH

    Acute Lymphoblastic Leukemia (ALL) in younger adults (18-59 years)

    phase 2 · other · active

    1 trial →

20. GS-US-576-6220

    Gilead Sciences Pty Limited

    Non-small cell lung cancer

    phase 2 · small molecule · active

    1 trial →

21. GS-US-699-7184-01

    Gilead Sciences Pty Limited

    Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

    phase 2 · small molecule · active

    1 trial →

22. GSK4418959

    IDEAYA Biosciences

    Neoplasms, Colorectal

    phase 2 · small molecule · active

    1 trial →

23. GT719 Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hematological Malignancy (Leukemia- Lymphoma)

    phase 2 · mab · active

    1 trial →

24. GTAEXS617

    RECURSION PHARMACEUTICALS, INC.

    Head and Neck Squamous Cell Carcinoma (HNSCC)

    phase 2 · small molecule · active

    1 trial →

25. GTI-2040

    Aptose Biosciences

    Acute Myeloid Leukemia

    phase 2 · mab · completed

    1 trial →

26. GTI-2040

    Aptose Biosciences

    Carcinoma, Renal Cell

    phase 2 · small molecule · completed

    1 trial →

27. GVA + HDAC Consolidation & Gilteritinib Maintenance

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia

    phase 2 · small molecule · active

    1 trial →

28. GVM±R regimen

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Peripheral T Cell Lymphoma

    phase 2 · small molecule · active

    1 trial →

29. Gallium Ga 68 Gozetotide

    United Therapeutics Europe Ltd

    Hepatocellular Carcinoma

    phase 2 · small molecule · completed

    1 trial →

30. Gamma-retroviral vector MP71 MC2 TCR16-3D9

    Disc Medicine

    advanced melanoma or HNSCC

    phase 2 · small molecule · active

    1 trial →

31. Ganoderma lucidum spore

    The First People's Hospital of Lianyungang

    Carcinoma, Non-Small-Cell Lung

    phase 2 · small molecule · active

    1 trial →

32. Gefitinib

    AstraZeneca

    Head and Neck Cancer

    phase 2 · small molecule · completed

    1 trial →

33. Gemcitabine

    ACTUATE THERAPEUTICS, INC.

    Sarcoma

    phase 2 · small molecule · terminated

    1 trial →

34. Gemcitabine

    Arcus Biosciences

    Biliary Tract Carcinoma

    phase 2 · small molecule · active

    1 trial →

35. Gemcitabine

    LEXICON PHARMACEUTICALS, INC.

    Locally Advanced Unresectable Pancreatic Adenocarcinoma

    phase 2 · small molecule · completed

    1 trial →

36. Gemcitabine

    Chongqing Precision Biotech Co., Ltd

    Pancreatic Cancer, Adult

    phase 2 · small molecule · terminated

    1 trial →

37. Gemcitabine

    Compass Therapeutics

    Metastatic Biliary Tract Cancer

    phase 2 · small molecule · active

    1 trial →

38. Gemcitabine

    Acrivon Therapeutics

    Head and Neck Squamous Cell Carcinoma

    phase 2 · small molecule · active

    1 trial →

39. Gemcitabine

    HALOZYME THERAPEUTICS, INC.

    Stage IV Pancreatic Cancer

    phase 2 · small molecule · completed

    1 trial →

40. Gemcitabine

    ACTUATE THERAPEUTICS, INC.

    Soft Tissue Sarcoma

    phase 2 · small molecule · terminated

    1 trial →

41. Gemcitabine

    Regeneron UK Limited

    Bladder Cancer

    phase 2 · small molecule · active

    1 trial →

42. Gemcitabine , Docetaxel

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sarcoma

    phase 2 · small molecule · completed

    1 trial →

43. Gemcitabine Oxaliplatin 5FU and Leucovorin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pancreatic Cancer

    phase 2 · small molecule · active

    1 trial →

44. Gemcitabine plus Cisplatin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Biliary Tract Cancer

    phase 2 · small molecule · active

    1 trial →

45. Gemcitabine+simvastatin

    Samsung Bioepis NL B.V.

    Pancreatic Cancer

    phase 2 · small molecule · completed

    1 trial →

46. Gemcitabine/Cisplatin

    BRIGHT MINDS BIOSCIENCES INC.

    Upper Tract Urothelial Carcinoma

    phase 2 · small molecule · active

    1 trial →

47. Genomically Directed Monotherapy

    Vera Therapeutics

    Malignant Neoplasm of Breast

    phase 2 · small molecule · completed

    1 trial →

48. Gentuximab

    The First People's Hospital of Lianyungang

    Advanced Gastric or Gastroesophageal Junction Cancer

    phase 2 · small molecule · completed

    1 trial →

Frequently asked questions